Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription.

Ibaragi, Soichiro; Yoshioka, Norie; Li, Shuping; Hu, Miaofen G; Hirukawa, Saori; Sadow, Peter M; Hu, Guo-Fu

Ibaragi, Soichiro; Yoshioka, Norie; Li, Shuping; Hu, Miaofen G; Hirukawa, Saori; Sadow, Peter M; Hu, Guo-Fu.

Affiliation

Ibaragi S; Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.

Clin Cancer Res ; 15(6): 1981-8, 2009 Mar 15.

Article in En | MEDLINE | ID: mdl-19276260

Subject(s)

Antineoplastic Agents/pharmacology; Framycetin/pharmacology; Prostatic Neoplasms/drug therapy; RNA, Ribosomal/genetics; Ribonuclease, Pancreatic/antagonists & inhibitors; Transcription, Genetic/drug effects; Angiogenesis Inhibitors/pharmacology; Animals; Cell Line, Tumor; Cell Proliferation/drug effects; Humans; Male; Mice; Prostatic Neoplasms/pathology; Proto-Oncogene Proteins c-akt/physiology; Ribonuclease, Pancreatic/physiology; Xenograft Model Antitumor Assays

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Ribonuclease, Pancreatic / Transcription, Genetic / RNA, Ribosomal / Framycetin / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2009 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google